TY - JOUR ID - 15746 TI - The Present Situation of Patellofemoral Arthroplasty in the Management of Solitary Patellofemoral Osteoarthritis JO - The Archives of Bone and Joint Surgery JA - ABJS LA - en SN - 2345-4644 AU - RODRIGUEZ-MERCHAN, E. Carlos AD - Department of Orthopaedic Surgery, La Paz University Hospital, Madrid, Spain Y1 - 2020 PY - 2020 VL - 8 IS - 3 SP - 325 EP - 331 KW - Isolated patellofemoral osteoarthritis KW - management KW - patellofemoral arthroplasty KW - Results DO - 10.22038/abjs.2020.15746 N2 - Patellofemoral (PF) osteoarthritis (OA) is a somewhat predominant illness, affecting up to 24% of women and 11% ofmen over the age of 55 years who suffer from symptomatic knee OA. The purposes of this narrative overview are tosummarize the present situation of patellofemoral arthroplasty (PFA) in the treatment of solitary PF-OA, and to givean account of the clinical results of PFA for the management of solitary PF degenerative OA of the knee. A CochraneLibrary and PubMed (MEDLINE) examination related to the position of PFA in PF-OA was carried out. A number ofpublications have encountered that PFA is an efficacious treatment for solitary PF-OA. Additionally, a systematic reviewdescribed fairly good results of PFA survivorship and functional outcomes at short- and mid-run follow-up in the settingof solitary PF-OA. Success of PFA depends on accurate patient selection rather than prosthetic failure or wear. In manyreports, the main cause of PFA failure is advancement of tibiofemoral OA. In contemporary times, encouraging resultshave been accomplished by the association of PFA and unicompartmental knee arthroplasty (UKA). In conclusion,patients with solitary PF-OA with severe anterior knee pain may be candidates for PFA. The success of the surgicalprocedure and the long-run survivorship of PFA are related to a good surgical technique and observation to meticulousindications and contraindications in patient selection. Newer prostheses have also played a part to amelioratedoutcomes. PFA is an alternative for younger patients with solitary PF-OA.Level of evidence: III UR - https://abjs.mums.ac.ir/article_15746.html L1 - https://abjs.mums.ac.ir/article_15746_7c535b0caceb27f44e70a4dc63961ecf.pdf ER -